Accelerate recruitment and raise rates of research participation through our growing global network of health system partners and sites
Ease patient burden and improve retention with digital patient engagement tools, and integrated in-home healthcare delivery and study visits
Accelerate clinical development with remote data collection and novel digital endpoints from our library of biomarkers across multiple therapeutic areas
Monitor and manage side effects, adverse events, and other safety concerns
Collect real-world evidence to inform R&D, commercial decision making, and lifecycle line extension
Developing and integrating digital biomarkers and SaMD into established care pathways
Monitoring and management of side effects, adverse events, and other safety concerns to mitigate risk and enable patients to avoid hospital stays during therapy
Algorithm-guided recommendations for therapy titration and dose optimization based on individual’s data and baseline to drive precision medicine delivery
Digital patient engagement programs for personalized condition management and improved patient adherence
Interested in learning more?
Just as we carefully gather and track biomarker data on every patient, we also study the results our partners have achieved using our technology.
global clinical trial results our partners have achieved using our technology
countries with clinical trial participants
increase in usage and dosage optimization of heart failure medication3
Without geographic and economic barriers, a more diverse patient pool can take part in clinical trials and receive the care they need
Remote patient management helps maintain protocol adherence and identify clinical deviations, improving patient experience and safety
Virtual visits from health and wellness professionals along with coordinated digital patient experience programs offer timely education and guidance on the patient’s specific condition
Reduced travel costs and time to clinics and trial sites for patients and caregivers
Increased patient engagement via daily personal care plans, progress tracking, and ongoing patient-specific education
3. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction, Akshay S. Desai, MD1,2; Taylor Maclean, MS1; Alexander J. Blood, MD1,2; et al,, JAMA Cardiol. 2020;5(12):1430-1434. doi:10.1001/jamacardio.2020.3757.
4. Biofourmis data on file.
*Subject to geography and connectivity